⌘K
Loading ticker…
Intelligent Bio Solutions Inc. Common Stock · Healthcare · Medical Equipment
As of 2026-06-26, Intelligent Bio Solutions Inc. Common Stock (INBS) has a 3-month relative strength percentile of 9 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 30. The current market Stance is 47 (Neutral). Sector: Healthcare. Average daily range 6.2%, relative volume 0.29×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
9 is not yet a leadership-grade RS read, Market Stance is 47
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Daily range, ATR, beta, and the math for a 1-ADR stop.
INBS is in a stage 4 downtrend, week 6. Extended from base. VCP detected: inconclusive. Distance from 50d / 200d: -14.5% / -65.8%.
No attention data for this ticker yet — it joins the daily scan once a baseline builds.
INBS appears in 1 ETF as of Mar 2026: VXF at 0.00% weight, $19K notional.
Top 1 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value |
|---|---|---|
| VXFVanguard Extended Market ETF | 0.00% | $19K |
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | INBS Jan avg: 75.85% median: 8.45% win: 50% σ: 168.06% n: 4 2022-10-28 → 2026-05-29 | INBS Feb avg: 2.61% median: -12.75% win: 50% σ: 75.10% n: 4 2022-10-28 → 2026-05-29 | INBS Mar avg: -31.77% median: -29.50% win: 0% σ: 15.59% n: 4 2022-10-28 → 2026-05-29 | INBS Apr avg: -22.84% median: -22.00% win: 0% σ: 11.02% n: 4 2022-10-28 → 2026-05-29 | INBS May avg: 4.04% median: 7.53% win: 75% σ: 11.70% n: 4 2022-10-28 → 2026-05-29 | INBS Jun avg: 1.84% median: 1.83% win: 67% σ: 20.14% n: 3 2022-10-28 → 2026-05-29 (current) | INBS Jul avg: -23.37% median: -26.72% win: 0% σ: 13.86% n: 3 2022-10-28 → 2026-05-29 | INBS Aug avg: 0.17% median: 0.21% win: 67% σ: 2.38% n: 3 2022-10-28 → 2026-05-29 | INBS Sep avg: -18.61% median: -37.04% win: 33% σ: 35.84% n: 3 2022-10-28 → 2026-05-29 | INBS Oct avg: -27.77% median: -13.90% win: 0% σ: 34.99% n: 4 2022-10-28 → 2026-05-29 | INBS Nov avg: 15.04% median: -0.81% win: 50% σ: 56.85% n: 4 2022-10-28 → 2026-05-29 | INBS Dec avg: -7.86% median: -16.02% win: 25% σ: 37.31% n: 4 2022-10-28 → 2026-05-29 |